“Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study”, IMC J Med Sci, vol. 14, no. 2, pp. 11–18, Apr. 2021, doi: 10.3329/imcjms.v14i2.52826.